Page 22 - Annual Research Report 2018-19
P. 22

17



               Studying the in vivo anti-tumor activity of some active extracts obtained from Boswellia
                sacra using myeloid and colon cancers models using xenograft techniques.

               Studying  the  sub-acute,  long  term  toxicity  and  genotoxicity  of  one  of  the  most  active
                extract obtained from Boswellia sacra (standardized extract).

               Studying the in vitro and in vivo anticancer activity of Boswellia sacra essential oils using
                different techniques.

               Development of some novel nutraceuticals from frankincense and other medicinal plants.


             Training Program as A Part of Capacity Building

             A training program for five months to train four Omani pharmacists from March-beginning of

             August  2019  was organized  under the  supervision of  Prof.  Luay  (PI)  as  a  part of  capacity
             building program. The program involved lectures on recent advances in cancer technology,

             carcinogenesis and other related issues. In addition, the trainees were trained practically to
             extract the plant materials  from four endemic plants grown in Dhofar  region using different

             solvents.  Moreover,  they  were  also  trained  to  perform  in  vitro  anticancer  assays  on  those
             extracts obtained from the four plant materials using some human established cell lines. Finally,

             the resulted data was presented as posters to Dhofar 3rd Pharmacy conference held on 2 -3

             August 2019 in Salalah, Dhofar.


             Patents

             The Research centre with the support of the VC and the Department of Research submitted
             one national and one international patent application. The national patent application has been

             approved initially by the Ministry of Commerce and is now in evaluation stage whereas the
             International patent application submitted to South African patent agency has been approved

             and the patent number was assigned in January 2020.


               The  Antiasthmatic  Effect  of  a  novel  “Polyherbal  composition”  in  Guinea  pig  Model  of

                Airway  Inflammation.  Omani  patent  Application,  field  OM/P/2018/200312.  Date  of
                Application:07/10/2018.


               Boswellic  Acid  Extraction.  Application  No:2019/02740  Date  of  Application  02/05/2019.

                Our Reference P82964ZA00. Classified by Adams & Adams, Pretoria, South Africa.






                                   11  Annual Research Report for AY 2018-19
                                     th
   17   18   19   20   21   22   23   24   25   26   27